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INTRODUCTION
Smoking during pregnancy is associated with adverse repro-
ductive outcomes and health problems in the fetus and neo-
nate (1). It appears to be an independent risk factor for con-
duct disorder in male offspring (2). A meta-analysis for the
effects of smoking on pregnancy complications revealed that
smoking during pregnancy is a significant and preventable
factor affecting ectopic pregnancy, placental abruption, pla-
centa previa, and premature rupture of the membrane (3).
Maternal smoking during pregnancy increases the risk of
having a child with a congenital anomaly (4, 5). 
In 2003, the prevalence of smoking during pregnancy was
reported at 10.7% in the United States (6). The US Depart-
ment of Health and Human Services estimated that if all
pregnant women in the United States quit smoking, there
would be an 11% reduction in stillbirths and a 5% reduc-
tion in newborn deaths (7). 
According to a telephone survey conducted in September
2006 by the Korean Association of Smoking and Health, the
prevalence of smoking among women of all ages was 2.8%.
The prevalence of smoking among women in their 20s and
30s were 3.4 and 2.2%, respectively (8). The reported preva-
lence of smoking among Korean women was thus much lower
than that in America or European countries. However, method-
ological limitations should be considered when interpreting
these data. Most surveys on the prevalence of smoking in Kore-
an women have depended on self-reporting or telephone inter-
views; however, respondents are often unwilling to disclose
their smoking habits in these situations. Nicotine is a high-
ly addictive substance, as potent as narcotics such as heroin
or cocaine (9). Therefore, despite widespread recognition of
the harmful effects of smoking, many addicted women are
unable to quit even when they are pregnant (10, 11). 
Little information is available regarding smoking and its
associated factors among pregnant women in Korea. There-
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Self-reported Smoking and Urinary Cotinine Levels among Pregnant
Women in Korea and Factors Associated with Smoking during 
Pregnancy 
This study examined urinary cotinine levels and self-reported smoking among preg-
nant women in Korea and the factors associated with smoking during pregnancy.
The subjects were selected from pregnant women who visited 30 randomly sam-
pled obstetric clinics and prenatal care hospitals in Korea in 2006. Smoking status
was determined by self-reporting and urinary cotinine measurement. A total of 1,090
self-administered questionnaires and 1,057 urine samples were analyzed. The per-
centage of smoking revealed by self-reporting was 0.55% (95% confidence inter-
val [CI], 0.11-0.99) and that revealed by urinary cotinine measurement (>100 ng/
mL) was 3.03% (95% CI, 1.99-4.06). The kappa coefficient of agreement between
self-reported smoking status and urinary cotinine measurement was 0.20 (95% CI,
0.03-0.37). Multiple logistic regression analysis revealed that early gestational peri-
od, low educational level, and being married to a smoker were significant risk fac-
tors for smoking during pregnancy. Smoking among pregnant women in Korea is
not negligible, and those who are concerned to maternal and child health should
be aware of this possibility among pregnant women in countries with similar cultur-
al background.
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fore, we investigated smoking status via two different meth-
ods, examined the relationship between self-reported habits
and clinically validated results, and analyzed associated fac-
tors of smoking in pregnant women in Korea.
MATERIALS AND METHODS
Subjects
This study was conducted from 22 May to 28 July 2006.
Subjects were selected from pregnant women who visited 30
randomly sampled obstetric clinics and hospitals in Korea
for prenatal care. According to the delivery number of each
administrative division (seven metropolitan cities and eight
provinces), we assigned the predicted number of study pop-
ulations. With the aid of Health Insurance Review and Assess-
ment Service, we got the annual delivery number of hospi-
tals which had over 500 deliveries per year. After sorting the
hospital by the number of delivery, we contacted each hospi-
tal for participation of this study and we stopped further con-
tact when the expected number of enrollment of each pro-
vince was reached. We visited at least one clinic or hospital
in each of the administrative divisions that were included in
this study. 
Smoking habits among pregnant women were ascertained
by two methods: voluntary disclosure through self-reporting
and urinary cotinine measurement. Subjects were asked to
respond to a self-administered questionnaire that inquired
about demographic data (age, marital status, educational level,
and duration of pregnancy in weeks), current smoking status
at the time of the survey, smoking habits for current smok-
ers (age at onset, duration, number of cigarettes per day), and
environmental tobacco smoke (ETS) exposure (spousal smok-
ing and the frequency of ETS exposure at home).
After the subjects completed the questionnaire, they were
asked to provide a urine sample. Urine samples were trans-
ported immediately and analyzed within 1-2 days. A clini-
cal laboratory researcher without knowledge of the subject’s
smoking history analyzed urinary cotinine concentration. Uri-
nary cotinine concentrations were determined by the DRI
cotinine assay for urine (Microgenics Corp., Fremont, CA,
USA) using a Toshiba 200FR automated clinical chemistry
analyzer (Toshiba Lab Medical, Tokyo, Japan). Briefly, 125 mL
of reagents containing a monoclonal antibody to cotinine and
an enzyme substrate were added to 20 mL of urine, and then
incubated with 125 mL of cotinine-conjugated glucose-6-phos-
phate dehydrogenase (G6PDH) at 37℃. The absorbance was
measured at 340 nm. Urinary cotinine concentrations were
determined without an adjustment for urinary creatinine.
We collected 1,135 questionnaires and 1,099 urine sam-
ples during the study period. We excluded those who did
not provide information on age, gestational period, their last
menstrual period, or smoking status. Consequently, 1,090
questionnaires and 1,057 urine samples were analyzed.
In the questionnaire, current smokers were defined as those
who were currently smoking or had smoked at least one ciga-
rette during the previous week. Ex-smokers were those who
reported quitting by the time of the survey. Non-smokers
were those who had never smoked. 
In urinary cotinine analysis, current smokers were defined as
those whose urinary cotinine levels exceeded 100 ng/mL.
Passive smokers and non-smokers showed urinary cotinine
levels of 40-100 ng/mL and <40 ng/mL, respectively. These
cut-off values were based on a recent study on the usefulness
of the urinary cotinine test to distinguish between smokers
and non-smokers (12). The Institutional Review Board of
Seoul National University Hospital approved the study pro-
tocol (SNUH-IRB 0602-070-168), and all subjects provid-
ed informed consent.
Statistical analysis
The kappa coefficient was calculated to evaluate the agree-
ment between self-reported smoking status and urinary coti-
nine levels in women who participated in both the question-
naire and urine analysis. Based on self-reported data, non-
smokers and ex-smokers were grouped into the non-smok-
ing category, and current smokers were placed in the smok-
ing category. Likewise, patients were divided into smoking
and non-smoking (passive and non-smokers) groups based
on the urine analysis data.
The Wilcoxon rank-sum test or Kruskal-Wallis test was
used to compare medians or ranks of urinary cotinine levels
according to the categories of explanatory variables. A mul-
tiple logistic regression model, using demographic data and
ETS exposure as explanatory variables and cotinine-validat-
ed smoking status (current smokers versus non-smokers) as
dependent variables, was constructed to evaluate the associ-
ated factors for smoking during pregnancy. The SAS statis-
tical package (SAS Institute, Cary, NC, USA) was used for
all statistical analyses.
RESULTS
Table 1 shows the self-reported smoking status of pregnant
women who participated in the questionnaire survey. Only six
women reported that they were current smokers or had smok-
ed at least one cigarette during the previous week. Therefore,
self-identified smokers composed only 0.55% (95% confidence
interval [CI], 0.11-0.99) of the study population. Among the
182 self-reported ex-smokers, 104 women reported that they
had quit before they became aware of being pregnant, and
78 women reported that they had quit after the fact. In self-
reporting questionnaires, some items were not responded. 
Table 2 shows the general characteristics and urinary coti-
nine-validated smoking status of pregnant women who par-754 H.-J. Jhun, H.-G. Seo, D.-H. Lee, et al.
ticipated in the urine analysis. The proportion of 30-39-yr-
old women was the largest (58.25%) among all participants.
Almost all women were married (98.01%). Most women had
graduated from college or university (70.96%) and over half
were in their third trimester (53.45%). Thirty-two women
showed urinary cotinine levels that exceeded 100 ng/mL, iden-
tifying them as current smokers. The percentage of smoking
as determined by urinary cotinine measurement was 3.03%
(95% CI, 1.99-4.06). Self-reported smoking status and urinary
cotinine did not agree in 30 women (2.84%; Table 3). The
kappa coefficient for these data was 0.20 (95% CI, 0.03-0.37). 
Urinary cotinine concentrations of women in the second
trimester were lower than those in the first or third trimester
(P<0.01). Urinary cotinine concentrations were also lower
in those who graduated from college or university compared
to those who graduated from middle or high school (P<0.05).
Urinary cotinine concentrations were higher in those exposed
to ETS 3-4 times per week or more compared to those exposed
to ETS less frequently (P<0.01). No significant differences
in urinary cotinine concentrations were observed with regard
to age, marital status, or smoking spouses (Table 4).
Multiple logistic regression analysis revealed that women
in their second trimester (0.15; 0.04-0.56) were less likely
to smoke than women in their first trimester. Women who
had graduated from middle or high school (5.70; 2.42-13.43)
or lived with a smoking spouse (3.45; 1.05-11.41) were more
likely to smoke than college or university graduates or women
married to non-smokers (Table 5). 
Smoking status Frequency (%)
Total 1,090
Smoking status
Current smoker 6 (0.55)
Ex-smoker 182 (16.70)
Non-smoker 902 (82.75)
Table 1. Self-reported smoking status in pregnant women who
responded to the questionnaire
Variables Frequency (%)
No. of total subjects 1,057
Age (yr)
18-19 2 (0.19)
20-29 431 (40.78)
30-39 616 (58.28)
≥40 8 (0.76)
Marital status
Married 1,036 (98.01)
Unmarried/divorced/other 21 (1.99)
Education
Below middle school 9 (0.85)
High school  291 (27.53)
College/university 750 (70.96)
Gestational period (weeks)
≤14 (First trimester) 185 (17.50)
15-28 (Second trimester) 307 (29.04)
≥29 (Third trimester)  565 (53.45)
Urinary cotinine level (ng/mL)
>100 (Current smoker)  32 (3.03)
40-100 (Passive smoker)  51 (4.82)
<40 (Non-smoker)  974 (92.15)
Table 2. General characteristics and urinary cotinine-validated
smoking status in pregnant women who participated in the urine
analysis
Based on self-reported data, non-smokers and ex-smokers were group-
ed into the non-smoking category, and current smokers were placed in
the smoking category; Based on urinary cotinine analysis, non-smok-
ers and passive smokers were grouped into the non-smoking catego-
ry, and current smokers were placed in the smoking category. Kappa
coefficient, 0.20 (95% CI, 0.03-0.37).
Self-reporting
Urinary cotinine
Non-smoking Smoking
Total
Non-smoking 1,023 (96.78) 28 (2.65) 1,051 (99.43)
Smoking 2 (0.19) 4 (0.38) 6 (0.57)
Total 1,025 (96.97) 32 (3.03) 1,057 (100)
Table 3. Agreement between self-reported and cotinine-validat-
ed smoking status
The Wilcoxon rank-sum test or Kruskal-Wallis test was used to compare
medians or ranks among the categories of selected variables. 
Variables
Concentration
(mean±SD,
ng/mL)
Frequency
(%)
P
Age (yr) 0.2389
18-29 433 (41.0) 23.9±101.0
≥30 624 (59.0) 17.5±85.1
Gestational period (weeks) <0.0001
≤14 (First trimester) 185 (17.5) 25.8±111.1
15-28 (Second trimester) 307 (29.0) 7.5±67.4
>29  (Third trimester) 565 (53.5) 25.1±96.0
Marital status
Married 1,036 (98.0) 19.9±91.5 0.2344
Unmarried/divorced/others 21 (2.0) 31.1±114.0
Education 0.0159
Middle/high school 300 (28.6) 45.1±147.0
College/university 750 (71.4) 10.3±54.2
Smoking spouse 0.0979
Yes 570 (53.9) 28.2±110.1
No 487 (46.1) 10.7±63.2
Frequency of ETS exposure at home 0.0058
None    477 (46.8) 13.2±72.9
1-2/week-1-3/month 338 (33.2) 10.8±49.9
≥3-4/week 204 (20.0) 52.1±159.7
Table 4. Urinary cotinine concentrations in relation to demogra-
phic data and environmental tobacco smoke (ETS) exposureSmoking among Pregnant Women in Korea 755
DISCUSSION
There is an overwhelming belief that smoking during preg-
nancy in Korea is negligible. This may be the result of the con-
tinuously reported low prevalence of smoking among women
(13). In addition, there is no previous research regarding the
prevalence of smoking among pregnant Korean women. The
self-reported smoking status (0.55%) in this study appears
to concur with the common opinion; however, the percent-
age of smoking validated by urinary cotinine measurement
(3.03%) was higher than expected and higher than the results
of smoking rate in Korean women reported in the telephone
survey conducted by the Korean Association of Smoking and
Health (8). Our results cast doubt on the reportedly low pre-
valence of smoking among Korean women. 
We assured anonymity in our questionnaire. However, the
discrepancy between self-reported smoking and urinary coti-
nine levels suggests that the majority of pregnant Korean
women who smoke may not choose to reveal their smoking
status, even anonymously. General disapproval for women,
who smoke, especially while pregnant, may hinder truthful
self-reporting. West et al. (14) showed that self-reported smok-
ing prevalence underestimated the true value when compar-
ing self-reported smoking habits and cotinine-validated data
from England, the United States, and Poland. This discrep-
ancy may be exaggerated in East Asian countries, where Con-
fucianism has had a heavy traditional influence. Prenatal care
physicians must be mindful of this possibility when provid-
ing care for pregnant women.
Smoking biomarkers including urine cotinine are gener-
ally considered as useful measures to assess objectively the
smoking status. However, urine cotinine concentration may
be under cut-off value, even undetectable after a few days of
abstinence because it has a relative short half-life of 12-24 hr.
Therefore, urine cotinine is possible to underestimate smoking
status, especially in case of an irregular smoker. Two women
reported themselves as current smokers in the questionnaire,
but their urinary cotinine levels were less than 100 ng/mL:
urinary cotinine was 0 in the first subject and 48 ng/mL in
the second. Therefore, they were classified as a non-smoker
and a passive smoker, respectively. Dempsey et al. (15) exam-
ined the metabolism of nicotine and cotinine in ten healthy
pregnant volunteers who smoked. The smokers received infu-
sions of deuterium-labeled nicotine and cotinine during preg-
nancy and again after birth. The experiment revealed that
the clearance of nicotine and cotinine was significantly higher
(60 and 140%, respectively) during pregnancy, and that the
half-life of cotinine was much shorter (8.8 vs. 16.6 hr). These
results suggest that low cotinine levels observed during preg-
nancy do not necessarily reflect less smoke exposure, and that
cut-off levels used to classify smoking habits need to be estab-
lished for pregnant women.
This study showed that early gestational period, low edu-
cation level, and smoking spouses were significant risk fac-
tors for smoking during pregnancy. Although a smoker was
aware of her pregnancy, she sometimes required an extended
period to quit. This may explain why the first trimester (early
gestational period) was a risk factor for smoking during preg-
nancy. However, smoking prevalence of the 3rd trimester
returned to that of the 1st trimester. This means maternal
motivation of abstinence may be weakened because of rela-
tively less effects of smoking to fetus in the 3rd trimester and
highly addictive nature of smoking. We found that low edu-
cational level was also a risk factor, which is consistent with
previous studies (16, 17). Smoking spouses may also raise uri-
nary cotinine levels in pregnant women through ETS expo-
sure. Furthermore, a tendency to select a spouse with similar
socioeconomic and behavioral factors might explain why being
married to a smoker is a risk factor for smoking during preg-
nancy.
Several limitations should be considered when interpreting
our results. First, more than 70% of the subjects in this study
were college or university graduates. According to the Kore-
an National Census, the proportion of 20-39-yr-old women
who graduated from college or university was 56.7% (18).
Although no data were available regarding the educational
level of pregnant Korean women, it appeared that the over-
Variables
Cotinine-
validated
current 
smokers
(n=32)
Non-
smokers
(n=974)
Adjusted OR 
(95% CI) 
Age (yr)
18-29 388 (96.3) 15 (3.7) 0.90 (0.42-1.93)
≥30 586 (97.2) 17 (2.8) 1.00
Gestational period (weeks)
≤14 (First trimester) 172 (94.0) 11 (6.0) 1.00
15-28 (Second trimester) 304 (99.0) 3 (1.0) 0.15 (0.04-0.57)
>29 (Third trimester)  498 (96.5) 18 (3.5) 0.58 (0.24-1.36)
Marital status
Married 955 (97.0) 30 (3.0) 1.00
Unmarried/divorced/other 19 (90.5) 2 (9.5) 1.18 (0.22-6.40)
Education
Middle/high school 261 (91.6) 24 (8.4) 5.70 (2.42-13.43)
College/university 706 (98.9) 8 (1.1) 1.00
Smoking spouse
No 487 (98.9) 5 (1.1) 1.00
Yes 507 (94.9) 27 (5.1) 3.45 (1.05-11.41)
Frequency of ETS exposure at home
None 450 (98.5) 7 (1.5) 1.00
1-2/week-1-3/month 316 (98.1) 6 (1.9) 0.63 (0.19-2.03)
≥3-4/week 175 (90.7) 18 (9.3) 2.45 (0.88-6.80)
Table 5. Adjusted odds ratios (OR) of demographic data and
environmental tobacco smoke (ETS) exposure for cotinine-vali-
dated smoking in pregnant women
Cut-off values for urinary cotinine: current smoker, >100 ng/mL; non-
smoker, <40 ng/mL.
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all educational level of our subjects was higher than could be
expected. To find eligible subjects, we selected clinics and
hospitals in which more than 500 deliveries per year (i.e., 1.4
deliveries per day) were recorded. Because these clinics and
hospitals were inevitably located in medium-sized or large
cities, women with higher education might have been select-
ed more than those with lower education. It is possible that
real smoking rate may be higher than that of this study. Sec-
ond, among the 1,057 pregnant women who participated
in both the questionnaire and urinary cotinine analysis, only
six reported that they were current smokers. Therefore, we
could not include the respondents’ smoking characteristics
in the multiple logistic regression model for the analysis of
factors associated with smoking during pregnancy. Finally,
because this was a cross-sectional study, we could not predict
smoking behavior for women throughout their pregnancies. 
Smoking among pregnant women in Korea is not negli-
gible, and those who are concerned to maternal and child
health should be aware of this possibility among pregnant
women in countries with similar cultural background.
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